Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Morrey

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Antiviral Research|September 1, 1992
Murine retroviral disease-enhancing effects of a pyrimidinone immunomodulatorR P Warren, J D Morrey, R A Burger, et al.
Journal of Acquired Immune Deficiency Syndromes|December 1, 1992
HIV-1 LTR activation model: evaluation of various agents in skin of transgenic miceJ D Morrey, S M Bourn, T D Bunch, et al.
Annals of the New York Academy of Sciences|June 23, 1993
Immunomodulator effects on the Friend virus infection in genetically defined miceR W Sidwell, J D Morrey, K M Okleberry, et al.
Intervirology|January 1, 1994
Activation of the human immunodeficiency virus long terminal repeat by abrasion of the skin in transgenic miceJ D Morrey, S M Bourn, J L Morris, et al.
American Journal of Veterinary Research|December 1, 1996
Progression of Aleutian disease in natural and experimentally induced infections of minkM K Jackson, L C Ellis, J D Morrey, et al.
Antiviral Research|October 1, 1992
Suppression of murine retroviral disease by 2',3'-didehydro-2',3'-dideoxythymidine (D4T)R W Sidwell, M Hitchcock, K M Okleberry, et al.
Accounts of Chemical Research|September 20, 2006
Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?B Caughey, W S Caughey, D A Kocisko, et al.
Transgenic Research|October 10, 1997
Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice and subsequent resistance to Brucella abortusW A Reed, P H Elzer, F M Enright, et al.
Antiviral Research|October 1, 2003
Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812)R W Sidwell, K W Bailey, J D Morrey, et al.
Avian Diseases|January 1, 1987
Staphylococcosis of turkeys. 1. Portal of entry and tissue colonizationM M Jensen, W C Downs, J D Morrey, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Antiviral Research|September 1, 1992
Murine retroviral disease-enhancing effects of a pyrimidinone immunomodulatorR P Warren, J D Morrey, R A Burger, et al.
Journal of Acquired Immune Deficiency Syndromes|December 1, 1992
HIV-1 LTR activation model: evaluation of various agents in skin of transgenic miceJ D Morrey, S M Bourn, T D Bunch, et al.
Annals of the New York Academy of Sciences|June 23, 1993
Immunomodulator effects on the Friend virus infection in genetically defined miceR W Sidwell, J D Morrey, K M Okleberry, et al.
Intervirology|January 1, 1994
Activation of the human immunodeficiency virus long terminal repeat by abrasion of the skin in transgenic miceJ D Morrey, S M Bourn, J L Morris, et al.
American Journal of Veterinary Research|December 1, 1996
Progression of Aleutian disease in natural and experimentally induced infections of minkM K Jackson, L C Ellis, J D Morrey, et al.
Antiviral Research|October 1, 1992
Suppression of murine retroviral disease by 2',3'-didehydro-2',3'-dideoxythymidine (D4T)R W Sidwell, M Hitchcock, K M Okleberry, et al.
Accounts of Chemical Research|September 20, 2006
Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?B Caughey, W S Caughey, D A Kocisko, et al.
Transgenic Research|October 10, 1997
Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice and subsequent resistance to Brucella abortusW A Reed, P H Elzer, F M Enright, et al.
Antiviral Research|October 1, 2003
Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812)R W Sidwell, K W Bailey, J D Morrey, et al.
Avian Diseases|January 1, 1987
Staphylococcosis of turkeys. 1. Portal of entry and tissue colonizationM M Jensen, W C Downs, J D Morrey, et al.
Pageof 3